Skip to content
DraconiticResearch
Search Sources API
197,357 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY-NC-ND 4.0JACC: CardioOncology

Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework

  • Joe-Elie Salem1
  • Stephane Ederhy1
  • Meiying Zhang2
  • Marie Bretagne1
  1. 1Sorbonne Université, INSERM, CIC-2503, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Pharmacology, Paris, France
  2. 2Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Read full textDOICite

Related

  1. Research advances in Janus kinase inhibitors for immune checkpoint inhibitors-related myocarditis
    Jing Leng, Chenyu Wang, Chunmei Bai
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  2. Immune-checkpoint blockade and candidate predictive biomarkers in HIV-negative Kaposi sarcoma: current evidence and a practical research framework
    Yang Song, Yan Fang, Lin Zeng +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  3. Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath
    Tyler T Morad, Mohammad Keykhaei, Devon A Terraciano +3
    JACC: CardioOncologyPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  4. Integrated multi-omics identifies distinct immune signatures with diagnostic and therapeutic implications in immune checkpoint inhibitor-induced myocarditis
    Shi-Long Zhang, Qing-Qing Cai, Jian Zhang +9
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study
    Emilien Ezine, Angélique da Silva, Safa Idoudi +5
    TherapiesPeer-reviewedCC BY-NC-NDPharmacology & toxicologyHAL

Cite

BibTeXRIS
BibTeX
@article{salem2026rechallenge,
  title = {{Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework}},
  author = {Joe-Elie Salem and Stephane Ederhy and Meiying Zhang and Marie Bretagne},
  journal = {JACC: CardioOncology},
  year = {2026},
  month = jun,
  doi = {10.1016/j.jaccao.2026.05.009},
  url = {https://doi.org/10.1016/j.jaccao.2026.05.009},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework
AU  - Joe-Elie Salem
AU  - Stephane Ederhy
AU  - Meiying Zhang
AU  - Marie Bretagne
PY  - 2026
DA  - 2026/06/19
JO  - JACC: CardioOncology
DO  - 10.1016/j.jaccao.2026.05.009
UR  - https://doi.org/10.1016/j.jaccao.2026.05.009
SN  - 2666-0873
ER  -